Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures
- 1 December 1999
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 56 (6) , 2276-2285
- https://doi.org/10.1046/j.1523-1755.1999.00788.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Roles of Plasma Platelet-Activating Factor Acetylhydrolase in Allergic, Inflammatory, and Atherosclerotic DiseasesJapanese Circulation Journal, 1998
- Platelet-Activating Factor Levels and PAF Acetylhydrolase Activities in Patients with Primary GlomerulonephritisNephron, 1996
- Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.Journal of Clinical Investigation, 1995
- PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Platelet‐activating factor: a mediator for cliniciansJournal of Internal Medicine, 1995
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- Renal necrosis and the involvement of a single enzyme of the de novo pathway for the biosynthesis of platelet-activating factor in the rat kidney inner medullaBiochemical and Biophysical Research Communications, 1989
- Involvement of Platelet-Activating Factor in Renal ProcessesPublished by Elsevier ,1989
- Platelet-Activating Factor in Renal DiseasesAmerican Journal of Nephrology, 1989
- Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individualsBiochemical and Biophysical Research Communications, 1984